Carmichael Hill & Associates, Inc. Sanofi Transaction History

Carmichael Hill & Associates, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	SELL	$45.39 - $50.36 $28,232 - $31,323	-622 Reduced 80.88%	147 $7,000
Q1 2024 Apr 24, 2024	SELL	$45.75 - $52.48 $960 - $1,102	-21 Reduced 2.66%	769 $37,000
Q2 2023 Aug 04, 2023	SELL	$50.45 - $57.18 $8,980 - $10,178	-178 Reduced 18.39%	790 $42,000
Q3 2022 Nov 10, 2022	BUY	$37.22 - $100.5 $3,684 - $9,949	99 Added 11.39%	968 $37,000
Q4 2020 Jan 27, 2021	SELL	$45.3 - $51.62 $2,265 - $2,581	-50 Reduced 5.44%	869 $42,000
Q3 2020 Nov 12, 2020	BUY	$49.47 - $53.77 $2,473 - $2,688	50 Added 5.75%	919 $46,000
Q4 2019 Jan 30, 2020	BUY	$44.25 - $50.86 $38,453 - $44,197	869 New	869 $44,000

856

269M

1.48M

1.34M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $128B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Carmichael Hill & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Carmichael Hill & Associates, Inc. with notifications on news.